Company Overview - Nature's Sunshine Products, Inc. (NASDAQ: NATR) is a leading manufacturer of high-quality herbal and nutritional supplements [1][3] - The company markets and distributes nutritional and personal care products in over 40 countries [3] Upcoming Conference Call - Nature's Sunshine will conduct a conference call on July 31, 2025, at 5:00 p.m. Eastern time to discuss its financial results for the second quarter ended June 30, 2025 [1][2] - The call will be hosted by CEO Terrence Moorehead and CFO Shane Jones, followed by a question and answer period [2] Financial Results Announcement - The company will release its financial results in a press release prior to the conference call [1] - A replay of the conference call will be available after 8:00 p.m. Eastern time on the same day through August 14, 2025 [3] Contact Information - Investor relations can be reached through Gateway Group, Inc. at 1-949-574-3860 [4]

Core Viewpoint - Nature's Sunshine Products, Inc. is launching a secondary public offering of up to 2,854,607 shares of its common stock, which will be sold by Fosun Pharma USA, Inc. as the selling stockholder [1][2]. Group 1: Offering Details - The selling stockholder will receive all net proceeds from the offering, while Nature's Sunshine will not sell any shares or receive any proceeds [2]. - The company has agreed to potentially purchase up to $15.0 million of its common stock from the underwriters as part of its share repurchase program, but there is no guarantee that any shares will be purchased [3]. - D.A. Davidson & Co. is acting as the sole book-running manager for the offering, which is being conducted under a shelf registration statement filed with the SEC [4]. Group 2: Company Background - Nature's Sunshine Products is a leading manufacturer of herbal and nutritional supplements, marketing products in over 40 countries and ensuring high quality through its own manufacturing facilities [8].